Apr 23, 2025

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

Apr 01, 2025

Lantheus Completes Acquisition of Evergreen Theragnostics

Feb 26, 2025

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

Feb 21, 2025

Lantheus to Present at Upcoming Investor Conferences

Feb 12, 2025

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

Feb 05, 2025

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

Jan 30, 2025

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Jan 13, 2025

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market